Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prospect of discovering new biomarkers for ovarian cancer based on current knowledge of susceptibility loci and genetic variation (Review).

International journal of molecular medicine - 1 Nov 2019

Christophersen Mikael Kronborg, Høgdall Claus, Høgdall Estrid

Abstract excerpt

Ovarian cancer is the most lethal gynaecological malignancy. The cancer initially presents with non‑specific symptoms; thus, it is typically not discovered until the patient has reached the late, considerably more lethal, stages of the disease. Research focus is currently on finding novel biomarkers, especially for early detection and stratification of the disease. One promising approach has been to focus on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to BRIP1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MSH6 gene

Share to TP53 gene

Share to Genetic Predisposition to Disease

Share to Genome-Wide Association Study

Share to Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 31573049
DOI: 10.3892/ijmm.2019.4352

Genes

BRCA1
BRIP1
MSH6
RAD51C
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prospect of discovering new biomarkers for ovarian cancer based on current knowledge of susceptibility loci and genetic variation (Review).PMID 31573049Read ↗

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian CancerSemantic proximity Read ↗

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.Semantic proximity Read ↗

Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.Semantic proximity Read ↗

Epithelial ovarian cancer risk: A review of the current genetic landscapeSemantic proximity Read ↗

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Semantic proximity Read ↗

Pathogenic Variants in BRIP1, RAD51C, and RAD51D Identified with Multi-Gene Panel Testing for Hereditary CancersSemantic proximity Read ↗

Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Semantic proximity Read ↗

Developments in Genetics – a Better Management of Ovarian Cancer PatientsSemantic proximity Read ↗

Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.Semantic proximity Read ↗

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.Semantic proximity Read ↗

Epithelial Ovarian Cancer: Providing Evidence of Predisposition GenesSemantic proximity Read ↗

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.